Description
  • Value proposition

    Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population.
    At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses.
    Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world.

    Data Privacy Statement & Imprint: https://www.bayer.com/en/glob-li-bayer-en-dps-imprint.aspx

    Pharmaceuticals , Consumer Health, Crop Science, Life Sciences, Research, Innovation, Sustainability, Health Care, Digital Farming, Food Security, Science For Better, and Innovation

Entity interactions BETA
Entity TypeTweets Articles
Nagi Bioscience Nagi Bioscience
biotech, deeptech, Biotechnology Research
Not capitalistic
Partnership
Event

28 Mar 2022


European Pharmaceutical Review European Pharmaceutical Review
Pharmaceutical Manufacturing
Other

10 Feb 2023


Kienbaum Kienbaum
hrtech, consulting, Business Consulting and Services
Other

19 May 2022


Reporterre Reporterre
Other

23 May 2022


S2G Ventures S2G Ventures
Financial Services
Other

29 Apr 2022


Luiss Business School Luiss Business School
Higher Education, edtech
Other

4 Jun 2022


BioM Biotech Cluster Development GmbH BioM Biotech Cluster Development GmbH
Biotechnology Research
Other

15 Jun 2022

16 Feb 2024



MMA Global MMA Global
Advertising Services
Other

9 Sep 2022


LISAvienna LISAvienna
biotech, deeptech, healthtech, Biotechnology Research
Other

20 Feb 2023

30 Jun 2023



CCRM CCRM
biotech, deeptech, Biotechnology Research
Other

24 Jan 2022


Radars
Loading...